USPTO serial 86966710
TOOLGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 26, 2017
- Examiner
- KUYKENDALL, LYNDSEY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with TOOLGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Geumcheon-gu Seoul, KR
Geumcheon-gu Seoul, KR
Seoul, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell SHERIDAN ROSS P.C.1560 Broadway, Suite 1200Denver, CO 80202United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for the treatment of hereditary diseases; reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; reagents for use in testing genetic detecting mutation in prion genes for medical purposes; stem cells for medical purposes; biotechnological preparations for medical purposes for the treatment of hereditary diseases, namely, pharmaceutical preparations for the treatment of hereditary diseases; cells for medical purposes; diagnostic preparations for medical purposes; cultures of microorganisms for medical purposes; diagnostic preparations for veterinary purposes; biological preparations for medical or veterinary purposes for the treatment of hereditary diseases; surgical implants grown from stem cells; sanitary preparations for medical use | SECTION 8 - CANCELLED | — |
| 042 | Consultation and providing information in the fields of biomedicine; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; analysis of amino acid for medical purpose; scientific research in the fields of medicine, health and pharmacology; consultation and providing information in the field of pharmacology; structural and functional analysis of genomes; multiple nucleotide sequence analysis for scientific research purposes; scientific research in the fields of biology; consultation and providing information in the fields of biology; laboratory research in the field of biology; genetic testing for scientific research purposes; gene analysis for scientific research purposes; drug discovery services; protein analysis; stem cell testing for medical research purposes; research and development in the pharmaceutical and biotechnology fields; DNA testing; DNA analysis; DNA sequence analysis; DNA screening for scientific research purposes; research and development of DNA chips; biotechnology research; biological research; research and development of new products for others; research on the subject of pharmaceuticals; bacteriological research | SECTION 8 - CANCELLED | — |
| 044 | Medical and health services relating to DNA, genetics and genetic testing; genetic testing for medical purposes; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; provision of gene therapy for medical treatment purposes; genetic counseling for medical purposes; medical diagnostic services; physical examination services; performing diagnosis of diseases; medical services relating to the removal, treatment and processing of stem cells; DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; analysis of human biodata for medical purposes; medical pathology for the diagnosis and treatment of disease; plant nursery services; animal breeding; consultation and providing information in the fields of medicine and health; multiple nucleotide sequence analysis for medical diagnostic purposes; gene analysis for medical diagnostic purposes; stem cell testing for medical treatment and diagnosis | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TOOLGEN INCORPORATED
- Other trademarks owned by TOOLGEN INCORPORATED
- Other trademarks owned by TOOLGEN INCORPORATED
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TOOLGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 29, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 29, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 29, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 29, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 29, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 26, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 26, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 10, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 10, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 20, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 2, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 6, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 9, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jan 26, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 27, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 12, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2016 | NWAP | NEW APPLICATION ENTERED | — |